Literature DB >> 9714338

Cell cycle dependency of porphyrin uptake in a glioma cell line.

Y Shibata1, A Matsumura, F Yoshida, T Yamamoto, K Nakai, T Nose, I Sakata, S Nakajima.   

Abstract

We used a two-color analysis system to assess the porphyrin uptake and DNA content in four established cell lines of glioma employing flow cytometry (FCM). The FCM study revealed porphyrin uptake in all cells, regardless of the phase of the cell cycle they were in. However, those in the G0/G1 phase showed moderate uptake of porphyrin and those in the G2/M phase showed a higher uptake. These results indicated the advantage of using porphyrin as the carrier of tumor targeting agents as a therapeutic strategy for malignant tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714338     DOI: 10.1016/s0304-3835(98)00086-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Cell-cycle-dependent efficacy of photodynamic therapy with ATX-S10(Na).

Authors:  Munetaka Sano; Takahisa Furuta; Kenichiro Takahira; Masayoshi Kajimura; Hiroyuki Hanai; Eiji Kohno; Toru Hirano; Akira Hishida
Journal:  Lasers Med Sci       Date:  2005-05-24       Impact factor: 3.161

2.  Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors.

Authors:  Shinji Kawabata; Weilian Yang; Rolf F Barth; Gong Wu; Tianyao Huo; Peter J Binns; Kent J Riley; Owendi Ongayi; Vijay Gottumukkala; M Graça H Vicente
Journal:  J Neurooncol       Date:  2010-09-17       Impact factor: 4.130

3.  Rhenium-188 labelled meso-tetrakis[3,4-bis(carboxymethyleneoxy)phenyl] porphyrin for targeted radiotherapy: preliminary biological evaluation in mice.

Authors:  Zhi-yun Jia; Hou-fu Deng; Man-fei Pu; Shun-zhong Luo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-12       Impact factor: 9.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.